| P2093 | author name string | Xiaoyan Wang | |
| | Lijuan Chen | |
| | Yuquan Wei | |
| | Haoyu Ye | |
| | Buyun Ma | |
| | Jingqiang Zhu | |
| | Jianhong Yang | |
| | Wenshuang Wu | |
| | Taijin Wang | |
| P2860 | cites work | The DNA-damage response in human biology and disease | Q24606586 |
| | Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide | Q27670929 |
| | The DNA Damage Response: Making It Safe to Play with Knives | Q27861055 |
| | ATM and ATR: networking cellular responses to DNA damage | Q28143424 |
| | The DNA damage response: ten years after | Q28261230 |
| | Good cop, bad cop: the different faces of NF-kappaB | Q28291669 |
| | ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks | Q29614215 |
| | Cancer. p53, guardian of the genome | Q29615610 |
| | The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance | Q30425939 |
| | NF-kappaB activation by double-strand breaks | Q33343137 |
| | Phosphatases in the cellular response to DNA damage. | Q34198570 |
| | Cytometric assessment of DNA damage in relation to cell cycle phase and apoptosis | Q34334647 |
| | PIDD mediates NF-kappaB activation in response to DNA damage | Q34477303 |
| | Circumventing tumor resistance to chemotherapy by nanotechnology | Q34618357 |
| | Activation and regulation of ATM kinase activity in response to DNA double-strand breaks | Q34722727 |
| | EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy | Q35067875 |
| | Repair of endogenous DNA damage | Q35132488 |
| | Catalytic topoisomerase II inhibitors in cancer therapy. | Q35187762 |
| | Characteristics of gamma-H2AX foci at DNA double-strand breaks sites | Q35191534 |
| | DNA damage tumor suppressor genes and genomic instability | Q35755997 |
| | Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response | Q35832054 |
| | Chromosomal aberrations and genomic instability induced by topoisomerase-targeted antitumour drugs | Q35849665 |
| | Rethinking ovarian cancer: recommendations for improving outcomes | Q36050883 |
| | REV7 counteracts DNA double-strand break resection and affects PARP inhibition | Q36351056 |
| | IkappaB kinase complexes: gateways to NF-kappaB activation and transcription | Q36637874 |
| | DNA repair pathways and their implication in cancer treatment | Q37785855 |
| | Regulation of NF-κB signaling by caspases and MALT1 paracaspase | Q37814066 |
| | DNA topoisomerases as anticancer drug targets | Q37901390 |
| | Various modes of cell death induced by DNA damage | Q38064783 |
| | ATM and ATR as therapeutic targets in cancer | Q38289832 |
| | PARP inhibitors: A new era of targeted therapy | Q38364532 |
| | DNA polymerase η modulates replication fork progression and DNA damage responses in platinum-treated human cells | Q39061225 |
| | The comet assay: a comprehensive review | Q40604761 |
| | Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates | Q41582148 |
| | Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein | Q44285373 |
| | Different DNA lesions trigger distinct cell death responses in HCT116 colon carcinoma cells | Q44894534 |
| | The ATM protein is required for sustained activation of NF-kappaB following DNA damage | Q48211878 |
| | Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine. | Q52559484 |
| | Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo. | Q54445373 |
| | A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines | Q71805034 |
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| | NF-κB | Q411114 |
| P304 | page(s) | 52281-52293 | |
| P577 | publication date | 2016-07-20 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Millepachine, a potential topoisomerase II inhibitor induces apoptosis via activation of NF-κB pathway in ovarian cancer | |
| P478 | volume | 7 | |